A surface plasmon resonance （SPR） method was presented to discriminate hemodialyzed T-lymphocytes from the normal based on antibody--cell recognition. By dynamic reaction with fixed anti-human CD4 antibody, SPR could offer significant signals to distinguish hemodialyzed patients from the healthy controls within 200 s after the cell injection in respect of either rising speed or maximum binding capacity （p 〈 0.01）. The ratio method is also used to exclude the non-specific adsorption. The percentage of hemodialyzed patients＇ CD4＋ T ceils against the healthy control is 69 ± 18%. The most attractive of the present method is its ability to detect the intact and label-free lymphocytes, and further to detect the subpopulations, or proteins secreted by the desired lymphocytes subset.
Hai Yan WangJian Jun LiXiao Na CaoJi Ying XuMei Rong LiuYi Chen
